By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Proteon Therapeutics, Inc. 

4420 Madison Avenue
Suite 180
Kansas City  Missouri  64111  U.S.A.
Phone: 816-531-0028 Fax: 816-531-3079



Company News
Proteon (PRTO) Announces Second Quarter 2017 Financial Results 8/8/2017 1:09:37 PM
Proteon (PRTO) Announces Closing Of $22 Million Convertible Preferred Stock Financing 8/3/2017 11:53:01 AM
Proteon (PRTO) Announces $22 Million Private Placement 6/22/2017 8:54:32 AM
Proteon (PRTO) Receives FDA Breakthrough Therapy Designation For Vonapanitase 5/10/2017 10:40:11 AM
Proteon (PRTO) Announces First Quarter 2017 Financial Results 5/10/2017 10:06:51 AM
Proteon (PRTO) Announces Increase To Enrollment Of Ongoing Phase III PATENCY-2 Clinical Trial 5/3/2017 10:52:41 AM
Proteon (PRTO)'s Kidney Drug Flunks Must-Pass Phase III Trial 12/13/2016 5:33:21 AM
Proteon (PRTO) Announces Publication In The Journal Of Cardiovascular Pharmacology Of Promising Nonclinical Results For Vonapanitase In Peripheral Artery Disease 4/13/2016 7:56:37 AM
Proteon Therapeutics, Inc. (PRTO) To Present At The 2016 BIO CEO & Investor Conference February 8th 2/2/2016 8:10:27 AM
Proteon Therapeutics, Inc. (PRTO) To Present At The Oppenheimer 26th Annual Healthcare Conference December 9th 12/2/2015 8:20:14 AM